Results 291 to 300 of about 6,896,550 (362)
Hepatoma-derived growth factor and non-coding RNA network in ovarian cancer patients. [PDF]
Ganjali R+6 more
europepmc +1 more source
Loss‐of‐function mutations in the scaffold subunit of protein phosphatase 2A (PP2A), PPP2R1A, sensitize ovarian clear cell carcinoma to immune checkpoint blockade (ICB) by enhancing the interferon gamma response and promoting antitumor immune cell infiltration.
Matheus Henrique Dias, René Bernards
wiley +1 more source
Anti-Vascular Endothelial Growth Factor Crunch Syndrome in Proliferative Diabetic Retinopathy. [PDF]
Li Z, Zhang Y.
europepmc +1 more source
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira+14 more
wiley +1 more source
Effect of transforming growth factor beta receptor I inhibitors on myotube formation in vitro. [PDF]
De Saeytyd L+3 more
europepmc +1 more source
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian+10 more
wiley +1 more source
β-sitosterol suppresses fibroblast growth factor and epidermal growth factor receptors to induce apoptosis and inhibit migration in lung cancer: an in vitro study. [PDF]
Kan SA+9 more
europepmc +1 more source
Transcriptome analysis of chicken fibroblast following transforming growth factor β1-mediated activation. [PDF]
Hou T, Zhang L, Zhao L, Gao F, Xing T.
europepmc +1 more source
Intravitreal vascular endothelial growth factor inhibitor systemic and renal toxicity registry. [PDF]
Nguyen MD+14 more
europepmc +1 more source